Health and Fitness Health and Fitness
Wed, November 24, 2010
[ Wed, Nov 24th 2010 ] - Market Wire
Berger & Montague, P.C., and Brower Piven, P.C., .. Summary Notice of Proposed Settlement, Settlement
[ Wed, Nov 24th 2010 ] - Market Wire
SeraCare Life Sciences to Report Fourth Quarter a .. Results and Outline Fiscal 2011 Strategy on Dece
[ Wed, Nov 24th 2010 ] - Market Wire
Gilead Sciences reicht bei US-Arzneimittelbehrde .. assung fr Einzeltablettentherapie mit Truvada® u
Tue, November 23, 2010
[ Tue, Nov 23rd 2010 ] - Market Wire
Exelixis Announces Webcast of Annual R&D Day on December 2
[ Tue, Nov 23rd 2010 ] - Market Wire
Gilead Sciences to Present at the 22nd Annual Pip .. ray Healthcare Conference on Tuesday, November 30
[ Tue, Nov 23rd 2010 ] - Market Wire
Curis to Present at Piper Jaffray 22nd Annual Healthcare Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Vascular Solutions to Present at the 5th Annual C .. y Cardiovascular, Diabetes and Obesity Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Alnylam to Webcast Presentation at Piper Jaffray 22nd Annual Healthcare Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
IR Global Rankings Announces Agreement with Institutional Investor for its IR Global Events
[ Tue, Nov 23rd 2010 ] - Market Wire
Clinical Data, Inc. to Present at the 22nd Annual Piper Jaffray Health Care Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
GlaxoSmithKline and Dr. Reddya?s Agree to the Sale of US Penicillin Facility and Products
[ Tue, Nov 23rd 2010 ] - Market Wire
New Report Shows Half the Country Could Have Diab .. r Prediabetes at a Cost of $3.35 Trillion by 2020
[ Tue, Nov 23rd 2010 ] - Market Wire
Imaging Diagnostic Systems Installs Its CTLM® in Israel
[ Tue, Nov 23rd 2010 ] - Market Wire
CHINA HEALTH LABS &; DIAGNOSTICS LTD. ANNOUNCES CONTRACT TO SUPPLY 17 MOBILE FOOD SAFETY LABS
[ Tue, Nov 23rd 2010 ] - Market Wire
Norton Healthcare and Humana Launch Accountable Care Organization in Louisville, Ky.
[ Tue, Nov 23rd 2010 ] - Market Wire
Abiomed to Present at 22nd Annual Piper Jaffrey Healthcare Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Anika Therapeutics to Present at NYSSA Biotech and Specialty Pharmaceuticals Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
ZIOPHARM Oncology to Present at the 22nd Annual Piper Jaffray Health Care Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Gilead Sciences Submits New Drug Application to U .. le-Tablet Regimen of Truvada® and TMC278 for HIV
[ Tue, Nov 23rd 2010 ] - Market Wire
XenoPort Awarded Grant from The Michael J. Fox Foundation
[ Tue, Nov 23rd 2010 ] - Market Wire
St. Jude Medical Announces Final Results of its Exchange Offer for AGA Medical
[ Tue, Nov 23rd 2010 ] - Market Wire
Affymax to Webcast Analyst Briefing on Hematidea"/Peginesatide Development Program
[ Tue, Nov 23rd 2010 ] - Market Wire
Vertex Completes New Drug Application for Telaprevir for Hepatitis C
[ Tue, Nov 23rd 2010 ] - Market Wire
Unigene Completes Executive Management Team and N .. f Investor Relations and Corporate Communications
[ Tue, Nov 23rd 2010 ] - Market Wire
Northstar Healthcare Announces Results of TSX Continued-Listing Review
[ Tue, Nov 23rd 2010 ] - Market Wire
Somaxon Pharmaceuticals to Present at Piper Jaffray 22nd Annual Healthcare Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Covidien to Present at Piper Jaffray Health Care Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
Salix Pharmaceuticals to Present at Piper Jaffray Conference
[ Tue, Nov 23rd 2010 ] - Market Wire
UnitedHealthcare Introduces Pharmacy Saver for Medicare Plan Members
[ Tue, Nov 23rd 2010 ] - Market Wire
SuperGen to Present at New York Society of Securi .. ialty Pharmaceuticals Conference on November 30th

SuperGen to Present at New York Society of Security Analystsa? Biotech & Specialty Pharmaceuticals Conference on November 30th


Published on 2010-11-23 03:20:38 - Market Wire
  Print publication without navigation


DUBLIN, Calif.--([ BUSINESS WIRE ])--SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at The New York Society of Security Analystsa™ 14th Biotech & Specialty Pharmaceuticals Industry Investor Conference on Tuesday, November 30th in New York.

SuperGen's presentation will begin at 9:35 a.m. ET. A live webcast of the presentation will be available in the Investor Events section of the Company's Web site at [ www.supergen.com ]. The webcast will be archived for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit [ http://www.supergen.com ].

Contributing Sources